mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.1 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.1 |